PTS Diagnostics

Indianapolis, United States Founded: 1992 • Age: 34 yrs Acquired By Sinocare
Point-of-care diagnostic instruments are developed for disease testing.

About PTS Diagnostics

PTS Diagnostics is a company based in Indianapolis (United States) founded in 1992 was acquired by Sinocare in May 2016. The company has 211 employees. PTS Diagnostics offers products and services including A1CNow System, CardioChek Analyzers, and PTS Panels Test Strips. PTS Diagnostics operates in a competitive market with competitors including SD Biosensor, 1Drop Diagnostics, DiabetOmics, DxGen and Nova Biomedical, among others.

Operational Areas
Key Metrics

Products & Services of PTS Diagnostics

PTS Diagnostics offers a comprehensive portfolio of products and services, including A1CNow System, CardioChek Analyzers, and PTS Panels Test Strips.

A1CNow System
Diagnostic Device

Provides fast A1C results via fingerstick for diabetes monitoring.

CardioChek Analyzers
Diagnostic Device

Offers quick lipid panel testing for heart disease assessment.

PTS Panels Test Strips
Testing Accessories

Enables flexible testing with analyzers for various health metrics.

Investors in PTS Diagnostics

PTS Diagnostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Sinocare.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Point-of-care devices for chronic diseases are developed and marketed.
2002sinocare.comChangsha, China
Premium access

Investor details for PTS Diagnostics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of PTS Diagnostics

25 people are tracked at PTS Diagnostics (8 in leadership, 17 in team); the tracked headcount is 211.

NameRoleGroup
Jonathan Deal
Associate Director Of MarketingLeadership
Cliffe Allen
Vice President Of Sales, USLeadership
Jonathan Chapman
President and Chief Executive OfficerLeadership
Don Bellissimo
Director Of Channel SalesLeadership
Gary Johnson
National Sale DirectorLeadership
Will Benedict
VP And General ManagerLeadership
Andrew Greaves
Snr Director International SalesLeadership
Shelton Hand
Director, National DistributionLeadership
Matt Ruckman
Senior Marketing AssociateTeam
Jason Boesche
Materials ManagerTeam
Jessica Brooks
Manufacturing EngineerTeam
Jenna Schreckenghaust
Chemical Production ScientistTeam
Brian Baehl
Senior Firmware EngineerTeam
Jessica Gahimer
Human Resources ManagerTeam
Issa Emeish
Contracts AdministratorTeam
David Gloudemans
Production And Engineering ManagerTeam
Quynh Chu
Production Chemist 1Team
Adrianna Scheller
A1c Chemical Production ManagerTeam
Frank Layden
Process Engineering ManagerTeam
Abbey Braasch
Human Resources GeneralistTeam

5 more people are available in the full profile.

Premium access

Complete people profiles for PTS Diagnostics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of PTS Diagnostics

2 dated milestones of PTS Diagnostics across 24 years, from founding to its latest funding, stage changes and deals.

  1. Founded PTS Diagnostics is founded.
  2. Exit Acquired by Sinocare.

Competitors of PTS Diagnostics

PTS Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SD Biosensor, 1Drop Diagnostics, DiabetOmics, DxGen and Nova Biomedical, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
sdbiosensor.com2001Suwon-si, South Korea––
Biosensors for point-of-care diagnostics are developed by SD Biosensor.
1dropdx.com2012Neuchatel, Switzerland$7.75M–
Finger-prick point-of-care diagnostics are provided for biomarker testing.
diabetomics.com2008Hillsboro, United States$11M35
Point-of-care tests for diabetes and women's health risks are developed.
dxgenco.com2016–––
Point-of-care diagnostic products for diabetes and tuberculosis are provided.
novabiomedical.com1976Waltham, United States––
Developer of advanced blood testing analyzers and meters. This company manufactures and sells a wide variety of analyzers for hospital, point-of-care, blood bank, biotechnology, veterinary, and sports medicine applications. Products include blood gas analyzers, glucose meters, lactate meters, and cell culture analyzers. They also offer contract development and manufacturing services for other medical device companies. The analyzers utilize various measurement technologies, including potentiometric, amperometric, and spectrophotometric methods. The company provides complete technical support and product information globally.
biohermes.com2007Wuxi, China––
Provider of POC diagnostic devices and kits
epinex.com1997Tustin, United States$4.5M10
Glycated albumin measurement devices are developed for diagnostics.
hemocue.com1982Angelholm, Sweden––
Point-of-care tests for hematology and diabetes are developed and sold.
labradorhealth.com2021Tel Aviv, Israel––
Non-invasive testing devices for diabetes prevention are developed.
Premium access

Detailed competitors of PTS Diagnostics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of PTS Diagnostics

The website of PTS Diagnostics (ptsdiagnostics.com) receives about 5.7K visits a month.

  • Monthly visits
    5.7K

    ▼ 30% vs previous month

Similar websites

Websites whose visitors overlap most with PTS Diagnostics. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
stat-technologies.com
100%
–#2,785,214View details
medexsupply.com
91%
–#333,383View details
healthchecksystems.com
healthchecksystems.com
90%
–#5,150,295–
relionbgm.com
relionbgm.com
67%
–#1,522,073–
millermedicalsupplies.com
millermedicalsupplies.com
66%
–#4,248,739–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 10 similar websites and full traffic analytics for PTS Diagnostics

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 10 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Pts Diagnostics

Premium access

Complete news archive for PTS Diagnostics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to PTS Diagnostics

10 companies that operate in the same segment as PTS Diagnostics (Diabetes), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of devices for continuous glucose monitoring and manual insulin delivery
2008San Diego, California, United StatesUSD 100.73 MUSD 1.02 B2,650
Wearable glucose monitoring patches are provided for real-time data tracking.
1999San Diego, California, United StatesUSD 52.5 MUSD 4.66 B10,300
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Small molecule drugs for various therapeutic areas are developed.
1995United StatesUSD 165 MUSD 49.8 M103
Implantable continuous glucose monitoring systems are provided for diabetes management.
1996Germantown, United StatesUSD 175.46 MUSD 22.47 M117
Developer of a closed-loop automated insulin delivery system
2014Milpitas, California, United StatesUSD 214.51 M–133
Provider of workforce healthcare solutions
2015New York, New York, United StatesUSD 107.87 M–166
Diabetes care and reversal programs are provided to patients.
2021Bengaluru, Karnataka, IndiaUSD 26.7 MUSD 5.07 M677
Provider of smart devices for diabetes management for patients and doctors
2014San Francisco, California, United StatesUSD 245.2 M––
Genetically engineered cell therapies are developed for multiple disorders.
2018Seattle, Washington, United StatesUSD 821 M–194
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about PTS Diagnostics

PTS Diagnostics was founded in 1992.

PTS Diagnostics is headquartered in Indianapolis, United States. It is registered at Indianapolis, Indiana, United States.

PTS Diagnostics has 211 employees.

PTS Diagnostics was founded in 1992 and is headquartered in Indianapolis, United States. Operations focus on the medical diagnostics sector, where point-of-care blood collection devices, testing instruments, and information management systems are produced. These tools are applied in monitoring conditions such as heart disease and diabetes. Key products include the A1CNow system for diabetes management and the CardioChek analyzer for cardiac risk assessment.

PTS Diagnostics's top competitors include SD Biosensor, Nova Biomedical and 1Drop Diagnostics.

PTS Diagnostics offers A1CNow System, CardioChek Analyzers, and PTS Panels Test Strips.

PTS Diagnostics has 1 investor. Key investors include Sinocare.

Yes. PTS Diagnostics was acquired by Sinocare in May 2016.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available